---
pmid: '29878199'
title: Integrating glycomics and genomics uncovers SLC10A7 as essential factor for
  bone mineralization by regulating post-Golgi protein transport and glycosylation.
authors:
- Ashikov A
- Abu Bakar N
- Wen XY
- Niemeijer M
- Rodrigues Pinto Osorio G
- Brand-Arzamendi K
- Hasadsri L
- Hansikova H
- Raymond K
- Vicogne D
- Ondruskova N
- Simon MEH
- Pfundt R
- Timal S
- Beumers R
- Biot C
- Smeets R
- Kersten M
- Huijben K
- CDG group
- Linders PTA
- van den Bogaart G
- van Hijum SAFT
- Rodenburg R
- van den Heuvel LP
- van Spronsen F
- Honzik T
- Foulquier F
- van Scherpenzeel M
- Lefeber DJ
- CDG group
- Mirjam W
- Han B
- Helen M
- Helen M
- Peter VH
- Jiddeke VK
- Diego M
- Lars M
- Katja BH
- Jozef H
- Majid A
- Kevin C
- Johann TWN
journal: Hum Mol Genet
year: '2018'
full_text_available: false
doi: 10.1093/hmg/ddy213
---

# Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation.
**Authors:** Ashikov A, Abu Bakar N, Wen XY, Niemeijer M, Rodrigues Pinto Osorio G, Brand-Arzamendi K, Hasadsri L, Hansikova H, Raymond K, Vicogne D, Ondruskova N, Simon MEH, Pfundt R, Timal S, Beumers R, Biot C, Smeets R, Kersten M, Huijben K, CDG group, Linders PTA, van den Bogaart G, van Hijum SAFT, Rodenburg R, van den Heuvel LP, van Spronsen F, Honzik T, Foulquier F, van Scherpenzeel M, Lefeber DJ, CDG group, Mirjam W, Han B, Helen M, Helen M, Peter VH, Jiddeke VK, Diego M, Lars M, Katja BH, Jozef H, Majid A, Kevin C, Johann TWN
**Journal:** Hum Mol Genet (2018)
**DOI:** [10.1093/hmg/ddy213](https://doi.org/10.1093/hmg/ddy213)

## Abstract

1. Hum Mol Genet. 2018 Sep 1;27(17):3029-3045. doi: 10.1093/hmg/ddy213.

Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone 
mineralization by regulating post-Golgi protein transport and glycosylation.

Ashikov A(1)(2), Abu Bakar N(1)(2), Wen XY(3)(4), Niemeijer M(1), Rodrigues 
Pinto Osorio G(1), Brand-Arzamendi K(3)(4), Hasadsri L(5), Hansikova H(6), 
Raymond K(5), Vicogne D(7), Ondruskova N(6), Simon MEH(8), Pfundt R(9), Timal 
S(1)(2), Beumers R(2), Biot C(7), Smeets R(2), Kersten M(2), Huijben K(2); CDG 
group; Linders PTA(10), van den Bogaart G(10), van Hijum SAFT(11)(12), Rodenburg 
R(13), van den Heuvel LP(14), van Spronsen F(15), Honzik T(6), Foulquier F(7), 
van Scherpenzeel M(2), Lefeber DJ(1)(2); CDG group; Mirjam W(16), Han B(9), 
Helen M(17), Helen M(18), Peter VH(19), Jiddeke VK(20), Diego M(21), Lars M(22), 
Katja BH(23), Jozef H(24), Majid A(25), Kevin C(26), Johann TWN(27).

Author information:
(1)Department of Neurology, Donders Institute for Brain, Cognition and Behavior, 
Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
(2)Translational Metabolic Laboratory, Department Laboratory Medicine, Radboud 
University Medical Center, 6525 GA Nijmegen, The Netherlands.
(3)Zebrafish Centre for Advanced Drug Discovery & Keenan Research Centre for 
Biomedical Science, Li Ka Shing Knowledge Institute, St Michael's Hospital, 
Toronto, ON, Canada.
(4)Department of Medicine, Physiology & Institute of Medical Science, Faculty of 
Medicine, University of Toronto, ON, Canada.
(5)Division of Laboratory Genetics, Department of Laboratory Medicine and 
Pathology, Mayo Clinic, Rochester, MN, USA.
(6)Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, 
Charles University and General University Hospital in Prague, Prague, Czech 
Republic.
(7)CNRS-UMR 8576, Structural and Functional Glycobiology Unit, FRABIO, 
University of Lille, 59655 Villeneuve d'Ascq, France.
(8)Department of Genetics, University Medical Center Utrecht, Utrecht, The 
Netherlands.
(9)Department of Human Genetics, Radboud University Medical Center, 6525 GA 
Nijmegen, The Netherlands.
(10)Department of Tumor Immunology, Radboud University Medical Center, 6525 GA 
Nijmegen, The Netherlands.
(11)Center for Molecular and Biomolecular Informatics, Radboud Institute for 
Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, 
The Netherlands.
(12)NIZO, 6710 BA Ede, The Netherlands.
(13)Radboud Center for Mitochondrial Disorders, Translational Metabolic 
Laboratory, Department of Pediatrics, Radboud University Medical Center, 6525 GA 
Nijmegen, The Netherlands.
(14)Department of Pediatrics, Radboud University Medical Center, 6525 GA 
Nijmegen, The Netherlands.
(15)Division of Metabolic Diseases, Beatrix Children's Hospital, University 
Medical Center Groningen, PO BOX 30.001, 9700 RB Groningen, The Netherlands.
(16)Department of Clinical Chemistry, VU University Medical Center, Amsterdam, 
The Netherlands.
(17)Centre for Inherited Metabolic Disease, Evelina Children's Hospital, Guys 
and St Thomas NHS Foundation Trust, London SE1 7EH, UK.
(18)Department of Enzymology and Cellular Function, Institute of Child Health, 
Athens, Greece.
(19)Department of Metabolic Diseases, University Medical Center Utrecht, 
Utrecht, The Netherlands.
(20)Department of Clinical Genetics, VU University Medical Center, Amsterdam, 
The Netherlands.
(21)Genetics and Rare Diseases Research Division, Bambino Ges√π Children's 
Research Hospital, Rome, Italy.
(22)Department of Medical Biochemistry, Oslo University Hospital, and Faculty of 
Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
(23)Department of Child Neurology, University Hospital Stavanger, Stavanger, 
Norway.
(24)Department of Paediatrics, Tawam Hospital, Al-Ain, UAE.
(25)King Abdullah International Medical Research Centre, King Saud bin Abdul 
Aziz University for Health Sciences, Division of Genetics, Department of 
Pediatrics, King Abdullah Specialized Children Hospital, King Abdul Aziz Medical 
City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia.
(26)NSW Biochemical Genetics Service, The Children's Hospital at Westmead, 
Disciplines of Genetic Medicine & Child and Adolescent Health, The University of 
Sydney, NSW 2145, Australia.
(27)Department of Child Health, University Hospital of Wales, Cardiff, UK.

Genomics methodologies have significantly improved elucidation of Mendelian 
disorders. The combination with high-throughput functional-omics technologies 
potentiates the identification and confirmation of causative genetic variants, 
especially in singleton families of recessive inheritance. In a cohort of 99 
individuals with abnormal Golgi glycosylation, 47 of which being unsolved, 
glycomics profiling was performed of total plasma glycoproteins. Combination 
with whole-exome sequencing in 31 cases revealed a known genetic defect in 15 
individuals. To identify additional genetic factors, hierarchical clustering of 
the plasma glycomics data was done, which indicated a subgroup of four patients 
that shared a unique glycomics signature of hybrid type N-glycans. In two 
siblings, compound heterozygous mutations were found in SLC10A7, a gene of 
unknown function in human. These included a missense mutation that disrupted 
transmembrane domain 4 and a mutation in a splice acceptor site resulting in 
skipping of exon 9. The two other individuals showed a complete loss of SLC10A7 
mRNA. The patients' phenotype consisted of amelogenesis imperfecta, skeletal 
dysplasia, and decreased bone mineral density compatible with osteoporosis. The 
patients' phenotype was mirrored in SLC10A7 deficient zebrafish. Furthermore, 
alizarin red staining of calcium deposits in zebrafish morphants showed a strong 
reduction in bone mineralization. Cell biology studies in fibroblasts of 
affected individuals showed intracellular mislocalization of glycoproteins and a 
defect in post-Golgi transport of glycoproteins to the cell membrane. In 
contrast to yeast, human SLC10A7 localized to the Golgi. Our combined data 
indicate an important role for SLC10A7 in bone mineralization and transport of 
glycoproteins to the extracellular matrix.

DOI: 10.1093/hmg/ddy213
PMID: 29878199 [Indexed for MEDLINE]
